SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999, to receive the free SmallCapReview newsletter and be entered to win a Free iPod Touch visit http://www.smallcapreview.com.
Amtech Systems (Nasdaq: ASYS) $17.31. Today announced it has booked a record $187 million in total orders in its 2010 fiscal year ended September 30, 2010, including a record $161 million in solar orders. For the fourth quarter ended September 30, 2010, total orders were $49 million, including $41 million in solar orders.
J.S. Whang, Chief Executive Officer of Amtech, commented, “The record total orders we have generated this fiscal year reflect our continued success in supporting our existing customers and an increasing number of top tier solar customers that recognize our superior solar diffusion technology. We continue to see excellent quotation activity and remain focused on continued successful execution of our solar growth strategy and further expanding our solar market share.”
What They Do: Amtech Systems, Inc. manufactures capital equipment, including silicon wafer handling automation, thermal processing equipment and related consumables used in fabricating solar cells and semiconductor devices.
Clean Energy Fuels (Nasdaq: CLNE) $13.26, Today announced it has signed an agreement with Pilot Travel Centers LLC (Pilot) to build, own and operate public access, compressed and liquefied natural gas (CNG/LNG) fueling facilities at agreed-upon Pilot Flying J truck travel centers nationwide. Pilot Flying J operates over 550 truck travel centers in 43 states and six Canadian provinces. It is the largest truck-fueling operator in the country.
“Pilot Flying J is the clear leader in the truck stop and travel center industry. They have the best team and the best stations, and we are eager to begin our partnership with them. This is the critical link for Clean Energy to be able to roll out natural gas truck fueling services across the nation,” said Andrew J. Littlefair, Clean Energy President and CEO.
What They Do: Clean Energy is the largest provider of natural gas fuel for transportation in North America and a global leader in the expanding natural gas vehicle market.
Santarus, Inc. (Nasdaq: SNTS) $2.79. Today announced the publication of an integrated analysis of two randomized placebo-controlled clinical trials with RHUCIN (recombinant human C1 inhibitor, or rhC1INH), in the October issue of the peer reviewed Journal of Allergy and Clinical Immunology (JACI). The studies were conducted to evaluate the efficacy and safety of two dosage strengths of RHUCIN, an investigational drug, for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema (HAE). HAE is a human genetic disorder in which the patient is deficient in or lacks a functional plasma protein C1 inhibitor, resulting in an overreaction of the immune system.
In the JACI publication, Zuraw et al reported the pooled results of two similar but independent, randomized, placebo-controlled studies in 70 HAE patients. As advised by the respective Independent Data Monitoring Committees, both of the studies were halted when predefined interim analyses revealed statistically significant results for the primary and secondary endpoints with no apparent adverse safety findings.
What They Do: Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by specialists, including gastroenterologists, endocrinologists, allergists, immunologists and rheumatologists.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com. To follow us on Twitter visit http://twitter.com/SmallCapReview.
